TSN084 Treating Patients With Advanced Malignant Tumors
NCT06386705
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
114
Enrollment
INDUSTRY
Sponsor class
Conditions
Malignant Neoplasm
Interventions
DRUG:
TSN084
Sponsor
Tyligand Bioscience (Shanghai) Limited